Brolucizumab 49187-0226-01
- Manufacturer
- Lonza Ag
- Dosage Form
- Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- October 31, 2019
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brolucizumab | 127 mg/mL |
Selected Package
49187-0226-01Selected1000 mL in 1 BOTTLE (49187-0226-1)